| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |